Evofem Biosciences, Inc. short interest in 2021
In 2021, Evofem Biosciences, Inc.'s disclosed short interest ran from 12.79% of shares outstanding on 15 Jan 2021 to 15.58% on 31 Dec 2021, a change of +2.79 percentage points. The year's high was 27.92% on 30 Jun 2021 and its low 10.52% on 28 May 2021, averaging 16.41% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.03 days on 29 Oct 2021. Full history: Evofem Biosciences, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022
2021 in figures
- Start of year
- 12.79% (15 Jan 2021)
- End of year
- 15.58% (31 Dec 2021)
- Change
- +2.79 pp
- High
- 27.92% (30 Jun 2021)
- Low
- 10.52% (28 May 2021)
- Average
- 16.41%
- Highest days to cover
- 14.03 (29 Oct 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 12.79% | 4.64 | |
| 29 Jan 2021 | 11.70% | 3.62 | |
| 12 Feb 2021 | 11.61% | 1.87 | |
| 26 Feb 2021 | 11.57% | 1.64 | |
| 15 Mar 2021 | 10.99% | 1.58 | 10-K filed, results (8-K) |
| 31 Mar 2021 | 11.35% | 1.83 | |
| 15 Apr 2021 | 14.85% | 4.11 | |
| 30 Apr 2021 | 11.75% | 3.53 | |
| 14 May 2021 | 11.14% | 2.86 | 10-Q filed, results (8-K) |
| 28 May 2021 | 10.52% | 1.00 | |
| 15 Jun 2021 | 24.22% | 1.00 | |
| 30 Jun 2021 | 27.92% | 2.62 | |
| 15 Jul 2021 | 27.30% | 6.07 | |
| 30 Jul 2021 | 27.46% | 8.54 | |
| 13 Aug 2021 | 17.93% | 4.62 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 17.32% | 5.70 | |
| 15 Sep 2021 | 18.29% | 8.99 | |
| 30 Sep 2021 | 17.87% | 12.64 | |
| 15 Oct 2021 | 17.75% | 10.82 | |
| 29 Oct 2021 | 17.45% | 14.03 | results (8-K) |
| 15 Nov 2021 | 16.35% | 8.87 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 15.01% | 5.22 | |
| 15 Dec 2021 | 15.07% | 8.76 | |
| 31 Dec 2021 | 15.58% | 5.51 |
See also: Evofem Biosciences, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.